Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects. 2024

Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
National Institute on Drug Dependence and Beijing Key laboratory of Drug Dependence Research, Peking University, Beijing 100191, China; Department of Pharmacology, Peking University Health Science Center, Beijing 100191, China.

The rapid antidepressant effects of ketamine depend on the N-methyl-D-aspartate (NMDA) receptor containing 2B subunit (NR2B), whose function is influenced by its phosphorylated regulation and distribution within and outside synapses. It remains unclear if ketamine's rapid onset of antidepressant effects relies on the dynamic phosphorylated regulation of NR2B within and outside synapses. Here, we show that ketamine rapidlyalleviated depression-like behaviors and normalized abnormal expression of pTyr1472NR2B and striatal-enriched protein tyrosine phosphatase (STEP) 61 within and outside synapses in the medial prefrontal cortex (mPFC) induced by chronic unpredictable stress (CUS) and conditional knockdown of STEP 61, a key phosphatase of NR2B, within 1 hour after administration Together, our results delineate the rapid initiation of ketamine's antidepressant effects results from the restoration of NR2B phosphorylation homeostasis within and outside synapses. The dynamic regulation of phosphorylation of NR2B provides a new perspective for developing new antidepressant strategies.

UI MeSH Term Description Entries

Related Publications

Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
March 2018, Molecular psychiatry,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
December 2016, ACS medicinal chemistry letters,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
November 2017, Journal of pharmacological sciences,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
August 2019, British journal of anaesthesia,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
January 2015, Behavioural brain research,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
August 2000, Acta pharmacologica Sinica,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
October 2014, eLife,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
October 2016, The European journal of neuroscience,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
October 2013, Neuroscience bulletin,
Ke Wang, and Xuan Tan, and Kai-Mo Ding, and Xue-Zhu Feng, and Yu-Yu Zhao, and Wei-Li Zhu, and Guo-Hai Li, and Su-Xia Li
October 2002, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
Copied contents to your clipboard!